Tikva Allocell
Developing engineered, allogeneic (donor-derived) cell therapies for adult and pediatric patients with solid tumors
Funding history
1 round- $8M
Developing engineered, allogeneic (donor-derived) cell therapies for adult and pediatric patients with solid tumors